Sala de prensa


Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021

DURHAM, NC – March 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

Read More

Bioventus Announces Pricing of Initial Public Offering

DURHAM, NC – February 10, 2021 – Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of…

Read More

Bioventus Announces Launch of Initial Public Offering

DURHAM, NC  –  February 4, 2021 – Bioventus Inc. ("Bioventus" or the “Company”), today announced that it has commenced the initial public offering of…

Read More

Miguel O. Beltrán-Delgado Joins Bioventus as Senior Vice President of Operations

DURHAM, NC – January 19, 2021 – Bioventus, a global leader in Innovations For Active Healing, has appointed Miguel O. Beltrán-Delgado as Senior Vice…

Read More

Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA

DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…

Read More

Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy

DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…

Read More

Bioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief

DURHAM, NC – November 10 – Beginning January 1, 2021 Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through…

Read More

Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide

DURHAM, NC – September 22, 2020 – Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than…

Read More

Bioventus Reports First Use of its SIGNAFUSE Bioactive Bone Graft in Strip Format

DURHAM, NC – September 2, 2020 – Bioventus is sharing results of the first in-patient use of its new SIGNAFUSE Bioactive Bone Graft strips. Rick…

Read More

Bioventus Appoints Katrina Church Chief Compliance Officer

DURHAM, NC – August 24, 2020 – Bioventus, a global leader in orthobiologic solutions, has appointed Katrina Church as its Chief Compliance Officer,…

Read More

Buscar noticias


Consultas de prensa


Thomas Hill
Director de Comunicaciones Corporativas
919.474.6715
[email protected]

Descargar biblioteca


Logotipos corporativos y de marca
Descargar ahora

Imágenes de productos
Descargar ahora